Pali Research initiates coverage on LifePoint (Nasdaq: LPNT) with a Neutral.

Pali analyst says, "LPNT distresses us. We see the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE